Paul Korner - Jun 28, 2023 Form 4 Insider Report for AGILE THERAPEUTICS INC (AGRX)

Role
Chief Medical Officer
Signature
/s/ Geoffrey P. Gilmore. Attorney-in-fact
Stock symbol
AGRX
Transactions as of
Jun 28, 2023
Transactions value $
$0
Form type
4
Date filed
6/30/2023, 04:38 PM
Previous filing
Nov 14, 2022
Next filing
Aug 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGRX Common Stock Award $0 +13.5K $0.00 13.5K Jun 28, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Employee Stock Option (Right to Buy) Award $0 +4.5K $0.00 4.5K Jun 28, 2023 Common Stock 4.5K $2.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") which were granted on June 28, 2023. The RSUs will vest in four equal installments over four years upon the anniversary of the grant, such that the RSUs will be fully vested on June 28, 2027.
F2 This option was granted on June 28, 2023. 25% of the shares subject to the stock option vest on June 28, 2024, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on June 28, 2027.